{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:56:33Z","timestamp":1793066193114,"version":"4.5.0"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In recent decades, immunometabolism in cancers has emerged as an interesting target for treatment development. Indeed, the tumor microenvironment (TME) unique characteristics such as hypoxia and limitation of nutrients availability lead to a switch in metabolic pathways in both tumor and TME cells in order to support their adaptation and grow. Glioblastoma (GBM), the most frequent and aggressive primary brain tumor in adults, has been extensively studied in multiple aspects regarding its immune population, but research focused on immunometabolism remains limited. Here, we provide an overview of immunometabolism adaptation of myeloid cells in cancers with a specific focus on GBM and other brain tumors, before describing current therapeutic strategies targeting metabolic pathways. The main myeloid cells composing the GBM TME include tumor-associated macrophages (TAMs), which comprise both peripheral macrophages and local microglia, as well as myeloid-derived suppressor cells. The metabolic pathways involved in myeloid cell remodeling encompass the tricarboxylic acid cycle (TCA cycle), the lipid, glucose and amino acid metabolism and hypoxia. Developing treatments that target these metabolic pathways in tumor growth and its TME is a promising and increasing field. It includes both drug-repurposing and the development of innovative metabolic therapies. We finally provide an overview of all clinical trials in neuro-oncology involving treatments modifying cell metabolism and provide the preclinical rationale for both drugs already evaluated within clinical trials and potential candidates for future trials.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1431112","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:10:44Z","timestamp":1734912644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic adaptation of myeloid cells in the glioblastoma microenvironment"],"prefix":"10.3389","volume":"15","author":[{"given":"Nora","family":"Essakhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Baeza-Kallee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Lavignolle-Heguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Arg\u00fcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Tchoghandjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Tabouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41467-021-21117-3","article-title":"Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma","volume":"12","author":"Jung","year":"2021","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0025-8","article-title":"Multidimensional communication in the microenvirons of glioblastoma","volume":"14","author":"Broekman","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.acr.2019.03.004","article-title":"Immunometabolism: A new target for improving cancer immunotherapy","volume":"143","author":"Guo","year":"2019","journal-title":"Adv Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resistance Updates"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.013","article-title":"Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion","volume":"36","author":"Bellail","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00027.2007","article-title":"Diffusion in brain extracellular space","volume":"88","author":"Sykov\u00e1","year":"2008","journal-title":"Physiol Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1016\/j.cell.2023.08.043","article-title":"The local microenvironment drives activation of neutrophils in human brain tumors","volume":"186","author":"Maas","year":"2023","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.020","article-title":"Myeloid cells","volume":"36","author":"Kawamoto","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00560","article-title":"Increased levels of circulating and tumor-infiltrating granulocytic myeloid cells in colorectal cancer patients","volume":"7","author":"Toor","year":"2016","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9678168","article-title":"Myeloid cells in circulation and tumor microenvironment of colorectal cancer patients with early and advanced disease stages","volume":"2020","author":"Toor","year":"2020","journal-title":"J Immunol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1236824","article-title":"The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors","volume":"14","author":"Musca","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.09.005","article-title":"ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2584","article-title":"SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1 \u03b1 \u2013dependent glycolysis","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nop023","article-title":"Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties","volume":"12","author":"Rodrigues","year":"2010","journal-title":"Neuro Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3726","article-title":"Clinical relevance and suppressive capacity of human myeloid-derived suppressor cell subsets","volume":"24","author":"Lang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071386","article-title":"Evaluating leukocyte telomere length and myeloid-derived suppressor cells as biomarkers for prostate cancer","volume":"16","author":"Wakita","year":"2024","journal-title":"Cancers"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1303959","article-title":"High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP","volume":"14","author":"Dhar","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122264","article-title":"Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis","volume":"3","author":"Alban","year":"2018","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2393","article-title":"Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion","volume":"34","author":"Otvos","year":"2016","journal-title":"Stem Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa029","article-title":"The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction","volume":"22","author":"Himes","year":"2020","journal-title":"Neuro Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-019-0536-x","article-title":"The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion","volume":"7","author":"Pinton","year":"2019","journal-title":"J immunotherapy Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2023.03.26.534192","DOI":"10.1101\/2023.03.26.534192","article-title":"Distinct myeloid derived suppressor cell populations promote tumor aggression in glioblastoma","author":"Jackson","year":"2023","journal-title":"bioRxiv"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S210545","article-title":"LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression","volume":"11","author":"Chai","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577633","article-title":"The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma","volume":"357","author":"Chaudhary","year":"2021","journal-title":"J Neuroimmunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141083","article-title":"SLIT2\/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia","volume":"131","author":"Geraldo","year":"2021","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.603495","article-title":"The role of microglia in glioblastoma","volume":"10","author":"Geribaldi-Dold\u00e1n","year":"2021","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","volume":"2015","author":"R\u0151szer","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.immunol.20.091101.091806","article-title":"The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses","volume":"20","author":"Carreno","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00262-019-02423-8","article-title":"Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity","volume":"68","author":"Vidyarthi","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15773","article-title":"Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma","volume":"114","author":"Wu","year":"2023","journal-title":"Cancer Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.914236","article-title":"Single-cell transcriptomics revealed subtype-specific tumor immune microenvironments in human glioblastomas","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710695","article-title":"Single-cell transcriptomics of glioblastoma reveals a unique tumor microenvironment and potential immunotherapeutic target against tumor-associated macrophage","volume":"11","author":"Cui","year":"2021","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00835","article-title":"Single-cell atlas reveals complexity of the immunosuppressive microenvironment of initial and recurrent glioblastoma","volume":"11","author":"Fu","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Genome Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat Neurosci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3090","article-title":"Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes Malignant growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"THE EMERGING HALLMARKS OF CANCER METABOLISM","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","article-title":"The emerging role and targetability of the TCA cycle in cancer metabolism","volume":"9","author":"Anderson","year":"2018","journal-title":"Protein Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature25171","article-title":"A metabolic function of FGFR3-TACC3 gene fusions in cancer","volume":"553","author":"Frattini","year":"2018","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","article-title":"SCENITH: A flow cytometry based method to functionally profile energy metabolism with single cell resolution","volume":"32","author":"Arg\u00fcello","year":"2020","journal-title":"Cell Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: An emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.02.009","article-title":"Targeting lipid metabolism of macrophages: A new strategy for tumor therapy","author":"Shao","year":"2024","journal-title":"J Advanced Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"OncoImmunology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2956","article-title":"Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation","volume":"15","author":"Huang","year":"2014","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2006.03.003","article-title":"Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain","volume":"9","author":"Sun","year":"2006","journal-title":"Cancer Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3171\/2022.6.JNS2274","article-title":"Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles","volume":"138","author":"Himes","year":"2022","journal-title":"J Neurosurg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1038\/s41467-023-39683-z","article-title":"Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19034","article-title":"Long noncoding RNA HOXC-AS3 remodels lipid metabolism and promotes the proliferation of transformed macrophages in the glioma stem cell microenvironment by regulating the hnRNPA1\/CaM axis","volume":"9","author":"Sheng","year":"2023","journal-title":"Heliyon"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/BF01726240","article-title":"[amp]]Uuml;ber den Stoffwechsel von Tumoren im K\u00f6rper","volume":"5","author":"Warburg","year":"1926","journal-title":"Klin Wochenschr"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1042\/BST20160094","article-title":"The Warburg effect: 80 years on","volume":"44","author":"Potter","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.752404","article-title":"High expression of glycolytic genes in clinical glioblastoma patients correlates with lower survival","volume":"8","author":"Stanke","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1038\/s41467-021-25501-x","article-title":"Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nat Commun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.11.15659","article-title":"Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts","volume":"10","author":"Whitaker-Menezes","year":"2011","journal-title":"Cell Cycle"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2022.5357","article-title":"[amp]]lsquo;Reverse Warburg effect\u2019 of cancer\u2212associated fibroblasts (Review)","volume":"60","author":"Liang","year":"2022","journal-title":"Int J Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110216","article-title":"From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy","volume":"144","author":"Benny","year":"2020","journal-title":"Med Hypotheses"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36843","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00159-4","article-title":"Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities","volume":"2","author":"Garofano","year":"2021","journal-title":"Nat Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2017.02.001","article-title":"Cancer metabolism in space and time: Beyond the Warburg effect","volume":"1858","author":"Danhier","year":"2017","journal-title":"Biochim Biophys Acta (BBA) - Bioenergetics"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9850","DOI":"10.1038\/s41598-017-10464-1","article-title":"A dynamic metabolic flux analysis of myeloid-derived suppressor cells confirms immunosuppression-related metabolic plasticity","volume":"7","author":"Goffaux","year":"2017","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.192","article-title":"Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis","volume":"8","author":"Jian","year":"2017","journal-title":"Cell Death Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell programmed nutrient partitioning in the tumor microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"Am J Physiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.04.001","article-title":"HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity","volume":"11","author":"Zhang","year":"2007","journal-title":"Cancer Cell"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.590576","article-title":"Molecular crosstalk between MYC and HIF in cancer","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","article-title":"Expression of hypoxia-inducible factor 1\u03b1 in brain tumors","volume":"88","author":"Zagzag","year":"2000","journal-title":"Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of HIF-1\u03b1 Suppresses T cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11825","article-title":"Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1413933111","article-title":"Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients","volume":"111","author":"Crane","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-022-03215-3","article-title":"Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma","volume":"72","author":"Longhitano","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00278.x","article-title":"Recent advances in arginine metabolism: roles and regulation of the arginases","volume":"157","author":"Morris","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02347-3","article-title":"Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma","volume":"68","author":"Kesarwani","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now034","article-title":"Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8\/9 and arginase and suppress T cell function","volume":"18","author":"Gielen","year":"2016","journal-title":"Neuro Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc8929","article-title":"Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma","volume":"7","author":"Miska","year":"2021","journal-title":"Sci Adv"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113990","article-title":"Arginase-1+ Exosomes from reprogrammed macrophages promote glioblastoma progression","volume":"21","author":"Azambuja","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp Mol Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0902","article-title":"Immunosuppressive immature myeloid cell generation is controlled by glutamine metabolism in human cancer","volume":"7","author":"Wu","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2015.1056406","article-title":"Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia\/macrophages and monocyte-derived macrophages","volume":"16","author":"Choi","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12935-022-02731-7","article-title":"Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres","volume":"22","author":"Shim","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3171\/2014.10.JNS14759","article-title":"Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines","volume":"122","author":"Harvey","year":"2015","journal-title":"JNS"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2023.102704","article-title":"Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy","volume":"53","author":"Mendanha","year":"2023","journal-title":"Nanomedicine: Nanotechnology Biol Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3727\/096504007783338340","article-title":"Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines","volume":"16","author":"Ciusani","year":"2007","journal-title":"or"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14716","article-title":"Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression","volume":"8","author":"Tseng","year":"2017","journal-title":"Oncotarget"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npy009","article-title":"Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma","volume":"5","author":"Krauze","year":"2018","journal-title":"Neuro-Oncology Pract"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.31038\/cst.2020511","article-title":"The addition of Valproic acid to concurrent radiation therapy and temozolomide improves patient outcome: a Correlative analysis of RTOG 0525, SEER and a Phase II NCI trial","volume":"5","author":"Krauze","year":"2020","journal-title":"Cancer Stud Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28283","article-title":"A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma","volume":"67","author":"Su","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112240","article-title":"Discovery of new LXR\u03b2 agonists as glioblastoma inhibitors","volume":"194","author":"Chen","year":"2020","journal-title":"Eur J Medicinal Chem"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0102","article-title":"An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR\/AKT\/SREBP-1\/LDLR\u2013dependent pathway","volume":"1","author":"Guo","year":"2011","journal-title":"Cancer Discovery"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2676","article-title":"The LKB1\u2013AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23028","article-title":"Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models","volume":"8","author":"Valtorta","year":"2017","journal-title":"Oncotarget"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664149","article-title":"Imaging metformin efficacy as add-on therapy in cells and mouse models of human EGFR glioblastoma","volume":"11","author":"Valtorta","year":"2021","journal-title":"Front Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104484","article-title":"Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence","volume":"90","author":"Fuentes-Fayos","year":"2023","journal-title":"eBioMedicine"},{"key":"B114","doi-asserted-by":"publisher","first-page":"now174","DOI":"10.1093\/neuonc\/now174","article-title":"Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin","volume":"19","author":"Kim","year":"2016","journal-title":"NEUONC"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174222","article-title":"Metformin with temozolomide for newly diagnosed glioblastoma: results of phase I study and a brief review of relevant studies","volume":"14","author":"Ohno","year":"2022","journal-title":"Cancers"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03786-8","article-title":"A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma","volume":"153","author":"Porper","year":"2021","journal-title":"J Neurooncol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31811","article-title":"Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma","volume":"125","author":"Maraka","year":"2019","journal-title":"Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5297","article-title":"A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation","volume":"12","author":"Metts","year":"2023","journal-title":"Cancer Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-022-01221-8","article-title":"Canagliflozin inhibits glioblastoma growth and proliferation by activating AMPK","volume":"43","author":"Shoda","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082097","article-title":"Omeprazole inhibits glioblastoma cell invasion and tumor growth","volume":"12","author":"Jin","year":"2020","journal-title":"Cancers"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000677","article-title":"Metabolic modulation of glioblastoma with dichloroacetate","volume":"2","author":"Michelakis","year":"2010","journal-title":"Sci Transl Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-0047-4","article-title":"Phase 1 trial of dichloroacetate (DCA) in adults with recurrent Malignant brain tumors","volume":"32","author":"Dunbar","year":"2014","journal-title":"Invest New Drugs"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2019.23.1.29","article-title":"Decursin induces apoptosis in glioblastoma cells, but not in glial cells via a mitochondria-related caspase pathway","volume":"23","author":"Oh","year":"2019","journal-title":"Korean J Physiol Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/302084","article-title":"Potential role of thymosin- \u03b1 1 adjuvant therapy for glioblastoma","volume":"2009","author":"Sungarian","year":"2009","journal-title":"J Oncol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2021.12.011","article-title":"Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model","volume":"170","author":"Serra","year":"2022","journal-title":"Eur J Pharmaceutics Biopharmaceutics"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0226-8","article-title":"Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages","volume":"19","author":"Bohn","year":"2018","journal-title":"Nat Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01201","article-title":"CPT1A\/2-mediated FAO enhancement-A metabolic target in radioresistant breast cancer","volume":"9","author":"Han","year":"2019","journal-title":"Front Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112319","article-title":"A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages","volume":"135","author":"Ren","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discovery"},{"key":"B131","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg cells promote the SREBP1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived interferon-\u03b3","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1775-1","article-title":"Longitudinal molecular trajectories of diffuse glioma in adults","volume":"576","author":"Barthel","year":"2019","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092347","article-title":"Practical review on preclinical human 3D glioblastoma models: advances and challenges for clinical translation","volume":"12","author":"Soub\u00e9ran","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100192","article-title":"An integrated toolbox to profile macrophage immunometabolism","volume":"2","author":"Verberk","year":"2022","journal-title":"Cell Rep Methods"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3437-0_25","article-title":"Measuring the metabolic state of tissue-resident macrophages via SCENITH","volume":"2713","author":"Vogel","year":"2024","journal-title":"Methods Mol Biol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1038\/s41467-023-38403-x","article-title":"Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem","volume":"14","author":"Schwaiger-Haber","year":"2023","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1431112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:10:49Z","timestamp":1734912649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1431112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":136,"alternative-id":["10.3389\/fimmu.2024.1431112"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1431112","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"article-number":"1431112"}}